1. Home
  2. VCYT vs PAHC Comparison

VCYT vs PAHC Comparison

Compare VCYT & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veracyte Inc.

VCYT

Veracyte Inc.

HOLD

Current Price

$32.85

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo Phibro Animal Health Corporation

PAHC

Phibro Animal Health Corporation

HOLD

Current Price

$56.43

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCYT
PAHC
Founded
2006
1946
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.2B
IPO Year
2013
2014

Fundamental Metrics

Financial Performance
Metric
VCYT
PAHC
Price
$32.85
$56.43
Analyst Decision
Strong Buy
Hold
Analyst Count
7
4
Target Price
$44.00
$41.25
AVG Volume (30 Days)
551.5K
223.9K
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
0.91%
EPS Growth
164.52
1883.33
EPS
0.82
1.32
Revenue
N/A
$833,350,000.00
Revenue This Year
$13.76
$17.03
Revenue Next Year
$12.35
$3.82
P/E Ratio
$41.10
$41.39
Revenue Growth
N/A
4.12
52 Week Low
$22.61
$19.00
52 Week High
$50.71
$60.08

Technical Indicators

Market Signals
Indicator
VCYT
PAHC
Relative Strength Index (RSI) 48.26 54.96
Support Level $31.00 $50.72
Resistance Level $34.37 $56.64
Average True Range (ATR) 1.38 2.49
MACD 0.01 -0.18
Stochastic Oscillator 46.43 78.99

Price Performance

Historical Comparison
VCYT
PAHC

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

About PAHC Phibro Animal Health Corporation

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Share on Social Networks: